haematological malignancy
Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database
... Models that incorporate the effect of chronic health and spe- cific diagnoses on mortality, such as the Acute Physiology and Chronic Health Evaluation II (APACHE II) score and the Sim- plified Acute Physiology Score II ...
17
Emergency admission and survival from aggressive non-Hodgkin lymphoma : A report from the UK's population-based Haematological Malignancy Research Network
... The study is set within the Haematological Malignancy Research Network (HMRN: www.hmrn.org), a population-based patient cohort instigated in 2004 to generate ‘real world’ evidence-based data for research ...
9
Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network
... monest haematological malignancy and accounts for around half of all NHLs, is of particular interest since although it is curable with standardised chemotherapy administered over a 6e8 month period, ...
8
The impact of rheumatological disorders on lymphomas and myeloma : a report on risk and survival from the UK's population-based Haematological Malignancy Research Network
... UK’s Haematological Malignancy Research Network (HMRN) which, initiated 09/2004 with a catchment population approaching 4 million accrues ˜2400 haematological ma- lignancy diagnoses each year, ...
9
Lymphoma incidence, survival and prevalence 2004–2014 : sub-type analyses from the UK’s Haematological Malignancy Research Network
... 2004, full details of its structure, data collection methods and ethical approvals have been previously described (Smith et al, 2010). Briefly, within HMRN, patient care is provided by 14 hospitals organised into five ...
11
Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
... Haematological malignancies are commoner in older people, and patients with these diseases may also have significant or multiple co-morbidities that contribute to their death. Although we did not examine cause of ...
8
Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
... In addition, and with permission from their clinical teams, patients are asked to consent to being approached in the future for further research purposes. Reflecting the diversity of disease sub-types, different ...
9
Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
... with haematological malignancy is recognised as being complex and uncertain, with death sometimes occurring suddenly, unexpectedly, or very rapidly after diagnosis ...
8
Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy
... Demographic and clinical details of the included patients n=30a Characteristic Male sex 14 46.7 Age years 64 [14] Haematological malignancy diagnosis Acute lymphoblastic leukaemia 1 3.3 [r] ...
23
Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
... Data are from the UK’s Haematological Malignancy Research Network (HMRN; www. hmrn. org) which, with a catchment population of around 4 million that is sociodemographically representative of the UK as a ...
10
Preferred and actual place of death in haematological malignancy
... This UK study is embedded within an established population-based patient-cohort of haematological malignancies — the Haematological Malignancy Research Network (HMRN) (http://www.HMRN.org). Initiated ...
10
An investigation to optimise teicoplanin therapy in patients with haematological malignancy and Gram positive infection
... In 2010, our hospital introduced a higher target teicoplanin trough concentration of ≥ 20 mg/L by Day 3 for haematological malignancy patients. This study aimed to explore whether target trough concen- ...
288
Variability in trough total and unbound teicoplanin concentrations and achievement of therapeutic drug monitoring targets in adult patients with haematological malignancy
... FIG 5 Comparison of model-predicted versus observed trough total teicoplanin concentrations in study patients using measured creatinine clearance Measured CLcr model, and using estimated[r] ...
30
Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
... the kidney, skin and joints. SLE is notorious for its markedly heterogeneous clinical phenotype, with a multifactorial aetiology that depends on genetic, epigenetic and environmental in fl uences. 2 While mortality ...
7
Investigation of clonality and minimal residual disease in haematological malignancy using fluorescent in situ hybridization
... Kasprzyk A, Secker-Walker LM (1997) Clonal Involvement of Different Cell Lineages in Hyperdiploid and Philadelphia Positive Patients with Acute Lymphoblastic Leukaemi[r] ...
181
Paraneoplastic immunoglobulin A nephropathy and associated focal segmental glomerulosclerosis in asymptomatic low volume B-cell lymphoma – a case report
... and malignancy can also be co-incidental ...and haematological malig- nancy diagnosis, it is possible that the two pathologies are ...Notably, haematological malignancy chemotherapy and ...
7
Varicella in Children with Haematological Malignancies Outcome of Prevention and Treatment
... Varicella In Children With Haematological Malignancy Outcome Of Treatment And Prevention ' ORIGINAL ARTICLE Varicella In Children With Haematological Malignancy Outcome Of Treatment And Prevention C M[.] ...
7
Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis
... The unique case of a very rare congenital translocation between chromosomes X and Y, forming a dicentric chromosome dic(X;Y)(p22.33;p11.32), was detected when the proband was at an advanced age. An analysis of the ...
6
Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study
... Over the last few decades, the increased intensity of treatments in patients with haematological malignancies (HMs) has translated into an improved survival rate. As a consequence of more aggressive chemotherapies ...
10
HIV Infection and Malignancy
... Treatment of cancer in HIV-infected individuals follows the same general principles as for those not infected with HIV. The diagnosis of cancer should be confirmed pathologically. For patients with early stage disease, ...
12